Alzheimer's Disease: The Challenge of the Second Century

被引：1074

作者：

Holtzman, David M. ^{[1
,2
,3
,4
]}

Morris, John C. ^{[1
,3
,4
,5
]}

Goate, Alison M. ^{[1
,3
,4
,6
]}

机构：

[1] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA

[2] Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO 63110 USA

[3] Washington Univ, Sch Med, Hope Ctr Neurol Disorders, St Louis, MO 63110 USA

[4] Washington Univ, Sch Med, Knight Alzheimers Dis Res Ctr, St Louis, MO 63110 USA

[5] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA

[6] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA

来源：

SCIENCE TRANSLATIONAL MEDICINE | 2011年 / 3卷 / 77期

关键词：

AMYLOID-PRECURSOR-PROTEIN; MILD COGNITIVE IMPAIRMENT; PAIRED HELICAL FILAMENT; GENOME-WIDE ASSOCIATION; HEREDITARY CEREBRAL-HEMORRHAGE; CEREBROSPINAL-FLUID TAU; CENTRAL-NERVOUS-SYSTEM; A-BETA; APOLIPOPROTEIN-E; MOUSE MODEL;

D O I：

10.1126/scitranslmed.3002369

中图分类号：

Q2 [细胞生物学];

学科分类号：

071009 ; 090102 ;

摘要：

Alzheimer's disease (AD) was first described a little more than 100 years ago. It is the most common cause of dementia with an estimated prevalence of 30 million people worldwide, a number that is expected to quadruple in 40 years. There currently is no effective treatment that delays the onset or slows the progression of AD. However, major scientific advances in the areas of genetics, biochemistry, cell biology, and neuroscience over the past 25 years have changed the way we think about AD. This review discusses some of the challenges to translating these basic molecular and cellular discoveries into clinical therapies. Current information suggests that if the disease is detected before the onset of overt symptoms, it is possible that treatments based on knowledge of underlying pathogenesis can and will be effective.

引用

页数：17

共 219 条

[81] Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study [J].

Hansson, O ;

Zetterberg, H ;

Buchhave, P ;

Londos, E ;

Blennow, K ;

Minthon, L .

LANCET NEUROLOGY, 2006, 5 (03) :228-234

[82] Medicine - The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics [J].

Hardy, J ;

Selkoe, DJ .

SCIENCE, 2002, 297 (5580) :353-356

[83]

Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440

[84] Cortical Binding of Pittsburgh Compound B, an Endophenotype for Genetic Studies of Alzheimer's Disease [J].

Hinrichs, Anthony L. ;

Mintun, Mark A. ;

Head, Denise ;

Fagan, Anne M. ;

Holtzman, David M. ;

Morris, John C. ;

Goate, Alison M. .

BIOLOGICAL PSYCHIATRY, 2010, 67 (06) :581-583

[85] Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes [J].

Holcomb, L ;

Gordon, MN ;

McGowan, E ;

Yu, X ;

Benkovic, S ;

Jantzen, P ;

Wright, K ;

Saad, I ;

Mueller, R ;

Morgan, D ;

Sanders, S ;

Zehr, C ;

O'Campo, K ;

Hardy, J ;

Prada, CM ;

Eckman, C ;

Younkin, S ;

Hsiao, K ;

Duff, K .

NATURE MEDICINE, 1998, 4 (01) :97-100

[86] Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease [J].

Hollingworth, Paul ;

Harold, Denise ;

Sims, Rebecca ;

Gerrish, Amy ;

Lambert, Jean-Charles ;

Carrasquillo, Minerva M. ;

Abraham, Richard ;

Hamshere, Marian L. ;

Pahwa, Jaspreet Singh ;

Moskvina, Valentina ;

Dowzell, Kimberley ;

Jones, Nicola ;

Stretton, Alexandra ;

Thomas, Charlene ;

Richards, Alex ;

Ivanov, Dobril ;

Widdowson, Caroline ;

Chapman, Jade ;

Lovestone, Simon ;

Powell, John ;

Proitsi, Petroula ;

Lupton, Michelle K. ;

Brayne, Carol ;

Rubinsztein, David C. ;

Gill, Michael ;

Lawlor, Brian ;

Lynch, Aoibhinn ;

Brown, Kristelle S. ;

Passmore, Peter A. ;

Craig, David ;

McGuinness, Bernadette ;

Todd, Stephen ;

Holmes, Clive ;

Mann, David ;

Smith, A. David ;

Beaumont, Helen ;

Warden, Donald ;

Wilcock, Gordon ;

Love, Seth ;

Kehoe, Patrick G. ;

Hooper, Nigel M. ;

Vardy, Emma R. L. C. ;

Hardy, John ;

Mead, Simon ;

Fox, Nick C. ;

Rossor, Martin ;

Collinge, John ;

Maier, Wolfgang ;

Jessen, Frank ;

Ruether, Eckart .

NATURE GENETICS, 2011, 43 (05) :429-+

[87] Long-term effects of Aβ42 immunisation in Alzheimer's disease:: follow-up of a randomised, placebo-controlled phase I trial [J].

Holmes, Clive ;

Boche, Delphine ;

Wilkinson, David ;

Yadegarfar, Ghasem ;

Hopkins, Vivienne ;

Bayer, Anthony ;

Jones, Roy W. ;

Bullock, Roger ;

Love, Seth ;

Neal, James W. ;

Zotova, Elina ;

Nicoll, James A. R. .

LANCET, 2008, 372 (9634) :216-223

[88] Alzheimer's disease - Moving towards a vaccine [J].

Holtzman, David M. .

NATURE, 2008, 454 (7203) :418-420

[89] Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer's disease [J].

Holtzman, DM ;

Bales, KR ;

Tenkova, T ;

Fagan, AM ;

Parsadanian, M ;

Sartorius, LJ ;

Mackey, B ;

Olney, J ;

McKeel, D ;

Wozniak, D ;

Paul, SM .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (06) :2892-2897

[90] Correlative memory deficits, A beta elevation, and amyloid plaques in transgenic mice [J].

Hsiao, K ;

Chapman, P ;

Nilsen, S ;

Eckman, C ;

Harigaya, Y ;

Younkin, S ;

Yang, FS ;

Cole, G .

SCIENCE, 1996, 274 (5284) :99-102

← 4 5 6 7 8 9 10 11 12 13 →